NUVA

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Nuvasive Inc

NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400-person workforce in more than 40 countries serving surgeons, hospitals and patients.
CEO
J. Christopher Barry
Employees
2700
Headquarters

7475 Lusk Blvd
San Diego, California 92121-5707
Phone: 18589091800
www.nuvasive.com

News

NuVasive Receives Expanded Clearance From FDA For Precice Limb Lengthening Solution
Mar 20, 2023 11:30am

WASHINGTON (dpa-AFX) - NuVasive, Inc. (NUVA) announced it received 510(k) clearance from the FDA for the use of its Precice all-internal limb lengthening solution to include pediatric patients. Pr…


Source:Finanz Nachrichten
NuVasive received 510(k) clearance from FDA for the use of its Precice all-internal limb lengthening solution to include pediatric patients
Mar 20, 2023 11:09am

https://www.investing.com/news/assorted/nuvasive-received-510k-clearance-from-fda-for-the-use-of-its-precice-allinternal-limb-lengthening-solution-to-include-pediatric-patients-432SI-3034515


Source:Investing.com
NuVasive to Participate in Upcoming Investor Conferences
Feb 27, 2023 21:10pm

SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will participate in upcoming…


Source:PR Newswire
NuVasive PT Raised to $53 at Barclays
Feb 24, 2023 11:44am

https://www.investing.com/news/pro/nuvasive-pt-raised-to-53-at-barclays-432SI-3013603


Source:Investing.com
NuVasive PT Raised to $45 at JPMorgan
Feb 23, 2023 12:23pm

https://www.investing.com/news/pro/nuvasive-pt-raised-to-45-at-jpmorgan-432SI-3012020


Source:Investing.com
NuVasive PT Lowered to $45 at Baird
Feb 23, 2023 11:39am

https://www.investing.com/news/pro/nuvasive-pt-lowered-to-45-at-baird-432SI-3011883


Source:Investing.com
NuVasive, Inc. (NUVA) Q4 2022 Earnings Call Transcript
Feb 23, 2023 02:08am

NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ETCompany ParticipantsJuliet Cunningham - VP, IRChristopher Barry - CEO & DirectorMatthew…


Source:Seeking Alpha
NuVasive, Inc. Q4 Earnings Summary
Feb 22, 2023 21:30pm

WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: $24.08 million in Q4 vs. -$36.74 million in the same period last year. EPS: $0.42 in Q4 vs. -$0.71 in t…


Source:Finanz Nachrichten
NuVasive Non-GAAP EPS of $0.43 misses by $0.08, revenue of $305.4M misses by $5.61M
Feb 22, 2023 21:14pm

NuVasive press release (NUVA): Q4 Non-GAAP EPS of $0.43 misses by $0.08.Revenue of $305.4M (+1.1% Y/Y) misses by $5.61M.The Company expects 2023 net sales growth of 6%ꟷ8% on an…


Source:Seeking Alpha
NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales Guidance
Feb 22, 2023 21:05pm

Full-year 2022 net sales grew 5.5% as reported, 8.5% on a constant currency basis Continued strong international growth in 2022 U.S. cervical delivers growth of greater than 20% year-over-year driven by C360 2,000+ Pulse cases performed worldwide since commercial launch …


Source:PR Newswire
NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty
Feb 21, 2023 12:12pm

https://www.investing.com/news/assorted/nuvasive-enhances-c360-portfolio-with-expanded-indications-for-modulus-cervical-and-attrax-putty-432SI-3008947


Source:Investing.com
ALERT: The M&A Class Action Firm Announces the Investigation of NuVasive, Inc. - NUVA
Feb 14, 2023 00:42am

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered…


Source:PR Newswire
NuVasive Inc. (NASDAQ: NUVA) Forecast: Expect A -41.89% Drop Within A Few Months
Feb 11, 2023 19:00pm

NuVasive Inc. (NASDAQ:NUVA) shares, rose in value on Friday, 02/10/23, with the stock price down by -5.79% to the previous day’s close as strong demand from buyers drove the stock to $44.40. Actively observing the price movement in the last trading, the stock closed the session at $47.13, falling within a range of $43.54 and … NuVasive Inc. (NASDAQ: NUVA) Forecast: Expect A -41.89% Drop Within A Few Months Read More »


Source:Stocks Register
Enslaving stocks: NuVasive, Inc. (NASDAQ:NUVA -5.79%), The Charles Schwab Corporation (NYSE:SCHW 1.11%), XPO Logistics, Inc. (NYSE:XPO -6.92%)
Feb 11, 2023 11:14am

Technical analysis of these three Hot stocks (NUVA, SCHW, XPO) NuVasive, Inc. a USA based Medical Devices Company, belongs to a Healthcare Sector. The Charles Schwab Corporation a USA based … The post Enslaving stocks: NuVasive, Inc. (NASDAQ:NUVA -5.79%), The Charles Schwab Corporation (NYSE:SCHW 1.11%), XPO Logistics, Inc. (NYSE:XPO -6.92%) appeared first on Stocks Equity .


Source:Stock Equity
Globus Medical stock slide continues after a raft of downgrades after NuVasive deal
Feb 10, 2023 15:23pm

Globus Medical fell 3.4% on Friday after plunging 18% on Thursday after the announcement of an all-stock acquisition of NuVasive, prompting a slew of Wall Street…


Source:Seeking Alpha
NuVasive PT Raised to $47 at Baird
Feb 10, 2023 12:04pm

https://www.investing.com/news/pro/nuvasive-pt-raised-to-47-at-baird-432SI-3000532


Source:Investing.com
Truist Securities Downgrades NuVasive to Hold
Feb 10, 2023 08:26am

https://www.investing.com/news/pro/truist-securities-downgrades-nuvasive-to-hold-432SI-3000210


Source:Investing.com
Citi Downgrades NuVasive to Neutral
Feb 10, 2023 08:21am

https://www.investing.com/news/pro/citi-downgrades-nuvasive-to-neutral-432SI-3000204


Source:Investing.com
Beguiling stocks: NuVasive, Inc. (NASDAQ:NUVA 2.95%), ChargePoint Holdings, Inc. (NYSE:CHPT -2.63%)
Feb 10, 2023 05:17am

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Beguiling stocks: NuVasive, Inc. (NASDAQ:NUVA 2.95%), ChargePoint Holdings, Inc. (NYSE:CHPT -2.63%) appeared first on Stocks Equity .


Source:Stock Equity
NuVasive could see higher bid given valuation for Globus Medical deal - analyst
Feb 09, 2023 20:58pm

NuVasive (NUVA) could see another bidder come in over the top after agreeing to an all-stock sale to Globus Medical (GMED), according a Truist analyst


Source:Seeking Alpha
Morning Stocks Intraday Alert: NuVasive, Inc. (NASDAQ:NUVA 5.72%), Cybin Inc. (AMEX:CYBN -0.67%)
Feb 09, 2023 16:44pm

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Intraday Alert: NuVasive, Inc. (NASDAQ:NUVA 5.72%), Cybin Inc. (AMEX:CYBN -0.67%) appeared first on Stocks Equity .


Source:Stock Equity
Globus Medical near deal for NuVasive , valuing it a $3.2 billion - Bloomberg
Feb 09, 2023 11:53am

https://www.investing.com/news/pro/globus-medical-near-deal-for-nuvasive--valuing-it-a-32-billion--bloomberg-432SI-2999281


Source:Investing.com